Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Artesunate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Intestinal Neoplasms 2 Papillomavirus Infections 1 Malaria 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 CIN 2/3 1 Breast Neoplasms 1

Interventions

Trastuzumab 535 Paclitaxel 488 Cyclophosphamide 476 Docetaxel 421 Capecitabine 361 Letrozole 320 Fulvestrant 276 Doxorubicin 253 Tamoxifen 235 Carboplatin 234 Anastrozole 202 Radiotherapy 197 exemestane 190 Epirubicin 174 Bevacizumab 167 palbociclib 156 Lapatinib 152 Vinorelbine 146 pertuzumab 145 Gemcitabine 143 pembrolizumab 140 Surveys and Questionnaires 120 Exercise 116 Magnetic Resonance Spectroscopy 113 eribulin 105 Fluorouracil 103 Albumin-Bound Paclitaxel 102 Blood Specimen Collection 99 130-nm albumin-bound paclitaxel 93 Everolimus 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00764036 2017-08-01

ARTIC-M33/2

Heidelberg University

Phase 1 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡